KRT125P

Across TCGA pan-cancer cohorts, KRT125P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated KRT125P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher KRT125P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRT125P expression acts as an unfavorable survival marker.

THCA, KIRC, and COAD are the cancer types where KRT125P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.529	0.927	<.001	69	view →
KIRC	DFS	Tertile	IV	0.167	0.605	<.001	60	view →
COAD	OS	Tertile	IV	0.091	0.659	<.001	36	view →
GBM	OS	Tertile	All	0.024	0.416	<.001	18	view →
UCS	OS	Tertile	All	0.251	0.598	.044	18	view →
UCEC	OS	Tertile	All	0.843	0.929	.016	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

KRT125P–THCA (OS)

Open the THCA breakdown →